In line with these findings, Thümmler et al. [3] noted that in their case series, five patients out of nine with pharmacoresistant mental health disease presented functional CYP2D6 abnormalities (three patients > 2N (UM), one patient *4/*41 (PM), and one patient *3/*4 (PM)). This evidence concerns the gene CYP2D6 and psychiatric disorder.